title: Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
abstract: The purposes of this report are to reaffirm concordance difficulties with the acute myeloid leukemia (AML) French-American-British (FAB) classification, to present the frequency of previously delineated AML syndromes in pediatric patients and to describe additional characteristic AML profiles utilizing composite morphologic, cytogenetic and immunophenotypic data. Profiles of 124 children with acute myeloid leukemia (AML) and 13 children with myelodysplastic syndrome entered on the Childrens Cancer Group (CCG) pilot study CCG-2861 were examined. Concordance between institutions and reviewers for FAB designation was 65%. Discordance was found principally between M1 and M2, M2 and M4, and M4 and M5. In 49% of marrow specimens, leukemic blasts expressed at least one T lineage-related antigen; 24% expressed the B lineage-related antigen CD19. CDw14 correlated with FAB M4 or M5 morphology and was the only surface antigen associated with a specific FAB subtype. Normal karyotypes were found for 15% of the 75 children with satisfactory karyotype preparations. Recurring aberrations, found in 76% of children, included t(15;17)(q22;q11), t(8;21)(q22;q22), inv(16)(p13q22), rearrangements of band 11q23, t(6;9) (p23;q34), trisomy 8 and monosomy 7. Results from this pilot study and from the current CCG randomized trial correlating morphology, immunophenotyping and cytogenetics, will help to classify AML into unique subgroups with differing clinical consequences or therapy requirements.
authors.affiliation: Izaak Walton Killam Children's Hospital, Halifax.
authors.forename: D R
authors.initials: DR
authors.lastname: Barnard
authors.forename: D K
authors.initials: DK
authors.lastname: Kalousek
authors.forename: S R
authors.initials: SR
authors.lastname: Wiersma
authors.forename: B J
authors.initials: BJ
authors.lastname: Lange
authors.forename: D R
authors.initials: DR
authors.lastname: Benjamin
authors.forename: D C
authors.initials: DC
authors.lastname: Arthur
authors.forename: J D
authors.initials: JD
authors.lastname: Buckley
authors.forename: N
authors.initials: N
authors.lastname: Kobrinsky
authors.forename: S
authors.initials: S
authors.lastname: Neudorf
authors.forename: J
authors.initials: J
authors.lastname: Sanders
authors.forename: L P
authors.initials: LP
authors.lastname: Miller
authors.forename: D C
authors.initials: DC
authors.lastname: Shina
authors.forename: G D
authors.initials: GD
authors.lastname: Hammond
authors.forename: W G
authors.initials: WG
authors.lastname: Woods
mesh_terms: D000293:Adolescent; D000328:Adult; D000943:Antigens, Differentiation / Q000032:analysis; D001853:Bone Marrow / Q000473:pathology; D002648:Child; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000145:classification* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D008297:Male; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D010865:Pilot Projects; D014481:United States
chemical_list: D000943:Antigens, Differentiation